Literature DB >> 22564278

Intra-operative tumour detection and staging in colorectal cancer surgery.

J P Tiernan1, I Ansari, N A Hirst, P A Millner, T A Hughes, D G Jayne.   

Abstract

AIM: Surgical resection for colorectal cancer involves segmental resection and regional lymphadenectomy. The appropriateness of this 'one-size-fits-all' strategy is questioned as bowel cancer screening programmes result in a shift to earlier stage disease. Currently, the nodal status of a colorectal cancer can only be reliably determined by histopathological examination of the resected specimen. New methods of intra-operative staging are required to allow surgical resection to be tailored to the stage of the disease.
METHOD: A literature search was performed of PubMed and Embase databases using the terms 'colon' OR 'colorectal' AND 'intra-operative detection' OR 'intra-operative staging' OR 'intra-operative detection' OR 'radioimmunoguided surgery'. Articles published between January 1980 and January 2012 were included. Technologies that have the potential to allow intra-operative staging and treatment stratification were identified and further searches performed.
RESULTS: Established techniques such as sentinel lymph node mapping and radioimmunoguided surgery have benefited from combination with other technologies to allow real-time intra-operative staging. Intra-operative fluorescence, using naturally fluorescent biomarkers or fluorescent tumour probes, probably offers the most practical means of intra-operative lymph node staging and may be facilitated using nanotechnology. Optical coherence tomography and real-time elastography have the potential to provide an in vivo'virtual biopsy'.
CONCLUSION: Technological advances may allow accurate intra-operative lymph node staging to facilitate tailored surgical resection. This may become the next paradigm shift in colorectal cancer surgery.
© 2012 The Authors. Colorectal Disease © 2012 The Association of Coloproctology of Great Britain and Ireland.

Entities:  

Mesh:

Year:  2012        PMID: 22564278     DOI: 10.1111/j.1463-1318.2012.03078.x

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  8 in total

1.  Establishing the optimum lymph node yield for diagnosis of stage III rectal cancer.

Authors:  A Bhangu; R P Kiran; G Brown; R Goldin; P Tekkis
Journal:  Tech Coloproctol       Date:  2014-02-11       Impact factor: 3.781

Review 2.  Assessment of lymph node involvement in colorectal cancer.

Authors:  Mark L H Ong; John B Schofield
Journal:  World J Gastrointest Surg       Date:  2016-03-27

3.  The impact of electrode resistance on the biogalvanic characterisation technique.

Authors:  J H Chandler; D A Head; M E Hubbard; A Neville; D G Jayne; P R Culmer
Journal:  Physiol Meas       Date:  2016-12-29       Impact factor: 2.833

4.  Binding of Targeted Semiconducting Photothermal Polymer Nanoparticles for Intraperitoneal Detection and Treatment of Colorectal Cancer.

Authors:  Eleanor McCabe-Lankford; Bryce McCarthy; Margarita Arakelyan-Peters Berwick; Kiarash Salafian; Laura Galarza-Paez; Santu Sarkar; John Sloop; George Donati; April J Brown; Nicole Levi-Polyachenko
Journal:  Nanotheranostics       Date:  2020-03-26

Review 5.  Targeting Glycans and Heavily Glycosylated Proteins for Tumor Imaging.

Authors:  Ruben D Houvast; Mireille Vankemmelbeke; Lindy G Durrant; Manfred Wuhrer; Victor M Baart; Peter J K Kuppen; Lioe-Fee de Geus-Oei; Alexander L Vahrmeijer; Cornelis F M Sier
Journal:  Cancers (Basel)       Date:  2020-12-21       Impact factor: 6.639

6.  Antibody Targeted PET Imaging of 64Cu-DOTA-Anti-CEA PEGylated Lipid Nanodiscs in CEA Positive Tumors.

Authors:  Patty Wong; Lin Li; Junie Chea; Weidong Hu; Erasmus Poku; Todd Ebner; Nicole Bowles; Jeffrey Y C Wong; Paul J Yazaki; Stephen Sligar; John E Shively
Journal:  Bioconjug Chem       Date:  2020-01-30       Impact factor: 4.774

7.  Carcinoembryonic antigen is the preferred biomarker for in vivo colorectal cancer targeting.

Authors:  J P Tiernan; S L Perry; E T Verghese; N P West; S Yeluri; D G Jayne; T A Hughes
Journal:  Br J Cancer       Date:  2013-01-15       Impact factor: 7.640

8.  Survival Advantage Following TAG-72 Antigen-Directed Cancer Surgery in Patients With Colorectal Carcinoma: Proposed Mechanisms of Action.

Authors:  Charles L Hitchcock; Stephen P Povoski; Cathy M Mojzisik; Edward W Martin
Journal:  Front Oncol       Date:  2021-12-07       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.